report cover

Global Personalized Medicines Market Insights and Forecast to 2028

  • 13 May 2022
  • ICT & Media
  • 115 Pages
  • Report code : 24WT-7072998

Personalized Medicines Market

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 PM Diagnostics
1.2.3 PM Therapeutics
1.2.4 Personalized Medical Care
1.2.5 Personalized Nutrition & Wellness
1.3 Market by Application
1.3.1 Global Personalized Medicines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Dietary Care Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Personalized Medicines Market Perspective (2017-2028)
2.2 Personalized Medicines Growth Trends by Region
2.2.1 Personalized Medicines Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Personalized Medicines Historic Market Size by Region (2017-2022)
2.2.3 Personalized Medicines Forecasted Market Size by Region (2023-2028)
2.3 Personalized Medicines Market Dynamics
2.3.1 Personalized Medicines Industry Trends
2.3.2 Personalized Medicines Market Drivers
2.3.3 Personalized Medicines Market Challenges
2.3.4 Personalized Medicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Medicines Players by Revenue
3.1.1 Global Top Personalized Medicines Players by Revenue (2017-2022)
3.1.2 Global Personalized Medicines Revenue Market Share by Players (2017-2022)
3.2 Global Personalized Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Personalized Medicines Revenue
3.4 Global Personalized Medicines Market Concentration Ratio
3.4.1 Global Personalized Medicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicines Revenue in 2021
3.5 Personalized Medicines Key Players Head office and Area Served
3.6 Key Players Personalized Medicines Product Solution and Service
3.7 Date of Enter into Personalized Medicines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicines Breakdown Data by Type
4.1 Global Personalized Medicines Historic Market Size by Type (2017-2022)
4.2 Global Personalized Medicines Forecasted Market Size by Type (2023-2028)
5 Personalized Medicines Breakdown Data by Application
5.1 Global Personalized Medicines Historic Market Size by Application (2017-2022)
5.2 Global Personalized Medicines Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Personalized Medicines Market Size (2017-2028)
6.2 North America Personalized Medicines Market Size by Type
6.2.1 North America Personalized Medicines Market Size by Type (2017-2022)
6.2.2 North America Personalized Medicines Market Size by Type (2023-2028)
6.2.3 North America Personalized Medicines Market Share by Type (2017-2028)
6.3 North America Personalized Medicines Market Size by Application
6.3.1 North America Personalized Medicines Market Size by Application (2017-2022)
6.3.2 North America Personalized Medicines Market Size by Application (2023-2028)
6.3.3 North America Personalized Medicines Market Share by Application (2017-2028)
6.4 North America Personalized Medicines Market Size by Country
6.4.1 North America Personalized Medicines Market Size by Country (2017-2022)
6.4.2 North America Personalized Medicines Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Personalized Medicines Market Size (2017-2028)
7.2 Europe Personalized Medicines Market Size by Type
7.2.1 Europe Personalized Medicines Market Size by Type (2017-2022)
7.2.2 Europe Personalized Medicines Market Size by Type (2023-2028)
7.2.3 Europe Personalized Medicines Market Share by Type (2017-2028)
7.3 Europe Personalized Medicines Market Size by Application
7.3.1 Europe Personalized Medicines Market Size by Application (2017-2022)
7.3.2 Europe Personalized Medicines Market Size by Application (2023-2028)
7.3.3 Europe Personalized Medicines Market Share by Application (2017-2028)
7.4 Europe Personalized Medicines Market Size by Country
7.4.1 Europe Personalized Medicines Market Size by Country (2017-2022)
7.4.2 Europe Personalized Medicines Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Medicines Market Size (2017-2028)
8.2 Asia-Pacific Personalized Medicines Market Size by Type
8.2.1 Asia-Pacific Personalized Medicines Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Personalized Medicines Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Personalized Medicines Market Share by Type (2017-2028)
8.3 Asia-Pacific Personalized Medicines Market Size by Application
8.3.1 Asia-Pacific Personalized Medicines Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Personalized Medicines Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Personalized Medicines Market Share by Application (2017-2028)
8.4 Asia-Pacific Personalized Medicines Market Size by Region
8.4.1 Asia-Pacific Personalized Medicines Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Personalized Medicines Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Personalized Medicines Market Size (2017-2028)
9.2 Latin America Personalized Medicines Market Size by Type
9.2.1 Latin America Personalized Medicines Market Size by Type (2017-2022)
9.2.2 Latin America Personalized Medicines Market Size by Type (2023-2028)
9.2.3 Latin America Personalized Medicines Market Share by Type (2017-2028)
9.3 Latin America Personalized Medicines Market Size by Application
9.3.1 Latin America Personalized Medicines Market Size by Application (2017-2022)
9.3.2 Latin America Personalized Medicines Market Size by Application (2023-2028)
9.3.3 Latin America Personalized Medicines Market Share by Application (2017-2028)
9.4 Latin America Personalized Medicines Market Size by Country
9.4.1 Latin America Personalized Medicines Market Size by Country (2017-2022)
9.4.2 Latin America Personalized Medicines Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Medicines Market Size (2017-2028)
10.2 Middle East & Africa Personalized Medicines Market Size by Type
10.2.1 Middle East & Africa Personalized Medicines Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Personalized Medicines Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Personalized Medicines Market Share by Type (2017-2028)
10.3 Middle East & Africa Personalized Medicines Market Size by Application
10.3.1 Middle East & Africa Personalized Medicines Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Personalized Medicines Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Personalized Medicines Market Share by Application (2017-2028)
10.4 Middle East & Africa Personalized Medicines Market Size by Country
10.4.1 Middle East & Africa Personalized Medicines Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Personalized Medicines Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 3G Biotech
11.1.1 3G Biotech Company Details
11.1.2 3G Biotech Business Overview
11.1.3 3G Biotech Personalized Medicines Introduction
11.1.4 3G Biotech Revenue in Personalized Medicines Business (2017-2022)
11.1.5 3G Biotech Recent Developments
11.2 Quest Diagnostics
11.2.1 Quest Diagnostics Company Details
11.2.2 Quest Diagnostics Business Overview
11.2.3 Quest Diagnostics Personalized Medicines Introduction
11.2.4 Quest Diagnostics Revenue in Personalized Medicines Business (2017-2022)
11.2.5 Quest Diagnostics Recent Developments
11.3 Laboratory Corporation of America
11.3.1 Laboratory Corporation of America Company Details
11.3.2 Laboratory Corporation of America Business Overview
11.3.3 Laboratory Corporation of America Personalized Medicines Introduction
11.3.4 Laboratory Corporation of America Revenue in Personalized Medicines Business (2017-2022)
11.3.5 Laboratory Corporation of America Recent Developments
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott Personalized Medicines Introduction
11.4.4 Abbott Revenue in Personalized Medicines Business (2017-2022)
11.4.5 Abbott Recent Developments
11.5 Agendia NV
11.5.1 Agendia NV Company Details
11.5.2 Agendia NV Business Overview
11.5.3 Agendia NV Personalized Medicines Introduction
11.5.4 Agendia NV Revenue in Personalized Medicines Business (2017-2022)
11.5.5 Agendia NV Recent Developments
11.6 Asuragen Inc
11.6.1 Asuragen Inc Company Details
11.6.2 Asuragen Inc Business Overview
11.6.3 Asuragen Inc Personalized Medicines Introduction
11.6.4 Asuragen Inc Revenue in Personalized Medicines Business (2017-2022)
11.6.5 Asuragen Inc Recent Developments
11.7 Becton Dickinson
11.7.1 Becton Dickinson Company Details
11.7.2 Becton Dickinson Business Overview
11.7.3 Becton Dickinson Personalized Medicines Introduction
11.7.4 Becton Dickinson Revenue in Personalized Medicines Business (2017-2022)
11.7.5 Becton Dickinson Recent Developments
11.8 CardioDx Inc.
11.8.1 CardioDx Inc. Company Details
11.8.2 CardioDx Inc. Business Overview
11.8.3 CardioDx Inc. Personalized Medicines Introduction
11.8.4 CardioDx Inc. Revenue in Personalized Medicines Business (2017-2022)
11.8.5 CardioDx Inc. Recent Developments
11.9 Foundation Medicine
11.9.1 Foundation Medicine Company Details
11.9.2 Foundation Medicine Business Overview
11.9.3 Foundation Medicine Personalized Medicines Introduction
11.9.4 Foundation Medicine Revenue in Personalized Medicines Business (2017-2022)
11.9.5 Foundation Medicine Recent Developments
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Personalized Medicines Introduction
11.10.4 Qiagen Revenue in Personalized Medicines Business (2017-2022)
11.10.5 Qiagen Recent Developments
11.11 Siemens Healthcare
11.11.1 Siemens Healthcare Company Details
11.11.2 Siemens Healthcare Business Overview
11.11.3 Siemens Healthcare Personalized Medicines Introduction
11.11.4 Siemens Healthcare Revenue in Personalized Medicines Business (2017-2022)
11.11.5 Siemens Healthcare Recent Developments
11.12 Amgen
11.12.1 Amgen Company Details
11.12.2 Amgen Business Overview
11.12.3 Amgen Personalized Medicines Introduction
11.12.4 Amgen Revenue in Personalized Medicines Business (2017-2022)
11.12.5 Amgen Recent Developments
11.13 Bristol-Myers Squibb
11.13.1 Bristol-Myers Squibb Company Details
11.13.2 Bristol-Myers Squibb Business Overview
11.13.3 Bristol-Myers Squibb Personalized Medicines Introduction
11.13.4 Bristol-Myers Squibb Revenue in Personalized Medicines Business (2017-2022)
11.13.5 Bristol-Myers Squibb Recent Developments
11.14 GE Healthcare
11.14.1 GE Healthcare Company Details
11.14.2 GE Healthcare Business Overview
11.14.3 GE Healthcare Personalized Medicines Introduction
11.14.4 GE Healthcare Revenue in Personalized Medicines Business (2017-2022)
11.14.5 GE Healthcare Recent Developments
11.15 Pfizer
11.15.1 Pfizer Company Details
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Personalized Medicines Introduction
11.15.4 Pfizer Revenue in Personalized Medicines Business (2017-2022)
11.15.5 Pfizer Recent Developments
11.16 Sanofi
11.16.1 Sanofi Company Details
11.16.2 Sanofi Business Overview
11.16.3 Sanofi Personalized Medicines Introduction
11.16.4 Sanofi Revenue in Personalized Medicines Business (2017-2022)
11.16.5 Sanofi Recent Developments
11.17 23andMe
11.17.1 23andMe Company Details
11.17.2 23andMe Business Overview
11.17.3 23andMe Personalized Medicines Introduction
11.17.4 23andMe Revenue in Personalized Medicines Business (2017-2022)
11.17.5 23andMe Recent Developments
11.18 Illumina
11.18.1 Illumina Company Details
11.18.2 Illumina Business Overview
11.18.3 Illumina Personalized Medicines Introduction
11.18.4 Illumina Revenue in Personalized Medicines Business (2017-2022)
11.18.5 Illumina Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Global Personalized Medicines Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of PM Diagnostics
Table 3. Key Players of PM Therapeutics
Table 4. Key Players of Personalized Medical Care
Table 5. Key Players of Personalized Nutrition & Wellness
Table 6. Global Personalized Medicines Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Personalized Medicines Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Personalized Medicines Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Personalized Medicines Market Share by Region (2017-2022)
Table 10. Global Personalized Medicines Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Personalized Medicines Market Share by Region (2023-2028)
Table 12. Personalized Medicines Market Trends
Table 13. Personalized Medicines Market Drivers
Table 14. Personalized Medicines Market Challenges
Table 15. Personalized Medicines Market Restraints
Table 16. Global Personalized Medicines Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Personalized Medicines Revenue Share by Players (2017-2022)
Table 18. Global Top Personalized Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines as of 2021)
Table 19. Ranking of Global Top Personalized Medicines Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Personalized Medicines Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Personalized Medicines Product Solution and Service
Table 23. Date of Enter into Personalized Medicines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Personalized Medicines Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Personalized Medicines Revenue Market Share by Type (2017-2022)
Table 27. Global Personalized Medicines Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Personalized Medicines Revenue Market Share by Type (2023-2028)
Table 29. Global Personalized Medicines Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Personalized Medicines Revenue Share by Application (2017-2022)
Table 31. Global Personalized Medicines Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Personalized Medicines Revenue Share by Application (2023-2028)
Table 33. North America Personalized Medicines Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Personalized Medicines Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Personalized Medicines Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Personalized Medicines Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Personalized Medicines Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Personalized Medicines Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Personalized Medicines Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Personalized Medicines Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Personalized Medicines Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Personalized Medicines Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Personalized Medicines Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Personalized Medicines Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Personalized Medicines Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Personalized Medicines Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Personalized Medicines Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Personalized Medicines Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Personalized Medicines Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Personalized Medicines Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Personalized Medicines Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Personalized Medicines Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Personalized Medicines Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Personalized Medicines Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Personalized Medicines Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Personalized Medicines Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Personalized Medicines Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Personalized Medicines Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Personalized Medicines Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Personalized Medicines Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Personalized Medicines Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Personalized Medicines Market Size by Country (2023-2028) & (US$ Million)
Table 63. 3G Biotech Company Details
Table 64. 3G Biotech Business Overview
Table 65. 3G Biotech Personalized Medicines Product
Table 66. 3G Biotech Revenue in Personalized Medicines Business (2017-2022) & (US$ Million)
Table 67. 3G Biotech Recent Developments
Table 68. Quest Diagnostics Company Details
Table 69. Quest Diagnostics Business Overview
Table 70. Quest Diagnostics Personalized Medicines Product
Table 71. Quest Diagnostics Revenue in Personalized Medicines Business (2017-2022) & (US$ Million)
Table 72. Quest Diagnostics Recent Developments
Table 73. Laboratory Corporation of America Company Details
Table 74. Laboratory Corporation of America Business Overview
Table 75. Laboratory Corporation of America Personalized Medicines Product
Table 76. Laboratory Corporation of America Revenue in Personalized Medicines Business (2017-2022) & (US$ Million)
Table 77. Laboratory Corporation of America Recent Developments
Table 78. Abbott Company Details
Table 79. Abbott Business Overview
Table 80. Abbott Personalized Medicines Product
Table 81. Abbott Revenue in Personalized Medicines Business (2017-2022) & (US$ Million)
Table 82. Abbott Recent Developments
Table 83. Agendia NV Company Details
Table 84. Agendia NV Business Overview
Table 85. Agendia NV Personalized Medicines Product
Table 86. Agendia NV Revenue in Personalized Medicines Business (2017-2022) & (US$ Million)
Table 87. Agendia NV Recent Developments
Table 88. Asuragen Inc Company Details
Table 89. Asuragen Inc Business Overview
Table 90. Asuragen Inc Personalized Medicines Product
Table 91. Asuragen Inc Revenue in Personalized Medicines Business (2017-2022) & (US$ Million)
Table 92. Asuragen Inc Recent Developments
Table 93. Becton Dickinson Company Details
Table 94. Becton Dickinson Business Overview
Table 95. Becton Dickinson Personalized Medicines Product
Table 96. Becton Dickinson Revenue in Personalized Medicines Business (2017-2022) & (US$ Million)
Table 97. Becton Dickinson Recent Developments
Table 98. CardioDx Inc. Company Details
Table 99. CardioDx Inc. Business Overview
Table 100. CardioDx Inc. Personalized Medicines Product
Table 101. CardioDx Inc. Revenue in Personalized Medicines Business (2017-2022) & (US$ Million)
Table 102. CardioDx Inc. Recent Developments
Table 103. Foundation Medicine Company Details
Table 104. Foundation Medicine Business Overview
Table 105. Foundation Medicine Personalized Medicines Product
Table 106. Foundation Medicine Revenue in Personalized Medicines Business (2017-2022) & (US$ Million)
Table 107. Foundation Medicine Recent Developments
Table 108. Qiagen Company Details
Table 109. Qiagen Business Overview
Table 110. Qiagen Personalized Medicines Product
Table 111. Qiagen Revenue in Personalized Medicines Business (2017-2022) & (US$ Million)
Table 112. Qiagen Recent Developments
Table 113. Siemens Healthcare Company Details
Table 114. Siemens Healthcare Business Overview
Table 115. Siemens Healthcare Personalized Medicines Product
Table 116. Siemens Healthcare Revenue in Personalized Medicines Business (2017-2022) & (US$ Million)
Table 117. Siemens Healthcare Recent Developments
Table 118. Amgen Company Details
Table 119. Amgen Business Overview
Table 120. Amgen Personalized Medicines Product
Table 121. Amgen Revenue in Personalized Medicines Business (2017-2022) & (US$ Million)
Table 122. Amgen Recent Developments
Table 123. Bristol-Myers Squibb Company Details
Table 124. Bristol-Myers Squibb Business Overview
Table 125. Bristol-Myers Squibb Personalized Medicines Product
Table 126. Bristol-Myers Squibb Revenue in Personalized Medicines Business (2017-2022) & (US$ Million)
Table 127. Bristol-Myers Squibb Recent Developments
Table 128. GE Healthcare Company Details
Table 129. GE Healthcare Business Overview
Table 130. GE Healthcare Personalized Medicines Product
Table 131. GE Healthcare Revenue in Personalized Medicines Business (2017-2022) & (US$ Million)
Table 132. GE Healthcare Recent Developments
Table 133. Pfizer Company Details
Table 134. Pfizer Business Overview
Table 135. Pfizer Personalized Medicines Product
Table 136. Pfizer Revenue in Personalized Medicines Business (2017-2022) & (US$ Million)
Table 137. Pfizer Recent Developments
Table 138. Sanofi Company Details
Table 139. Sanofi Business Overview
Table 140. Sanofi Personalized Medicines Product
Table 141. Sanofi Revenue in Personalized Medicines Business (2017-2022) & (US$ Million)
Table 142. Sanofi Recent Developments
Table 143. 23andMe Company Details
Table 144. 23andMe Business Overview
Table 145. 23andMe Personalized Medicines Product
Table 146. 23andMe Revenue in Personalized Medicines Business (2017-2022) & (US$ Million)
Table 147. 23andMe Recent Developments
Table 148. Illumina Company Details
Table 149. Illumina Business Overview
Table 150. Illumina Personalized Medicines Product
Table 151. Illumina Revenue in Personalized Medicines Business (2017-2022) & (US$ Million)
Table 152. Illumina Recent Developments
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalized Medicines Market Share by Type: 2021 VS 2028
Figure 2. PM Diagnostics Features
Figure 3. PM Therapeutics Features
Figure 4. Personalized Medical Care Features
Figure 5. Personalized Nutrition & Wellness Features
Figure 6. Global Personalized Medicines Market Share by Application: 2021 VS 2028
Figure 7. Hospitals Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Dietary Care Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Personalized Medicines Report Years Considered
Figure 12. Global Personalized Medicines Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Personalized Medicines Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Personalized Medicines Market Share by Region: 2021 VS 2028
Figure 15. Global Personalized Medicines Market Share by Players in 2021
Figure 16. Global Top Personalized Medicines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Personalized Medicines Revenue in 2021
Figure 18. North America Personalized Medicines Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Personalized Medicines Market Size Market Share by Type (2017-2028)
Figure 20. North America Personalized Medicines Market Size Market Share by Application (2017-2028)
Figure 21. North America Personalized Medicines Market Size Share by Country (2017-2028)
Figure 22. United States Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Personalized Medicines Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Personalized Medicines Market Size Market Share by Type (2017-2028)
Figure 26. Europe Personalized Medicines Market Size Market Share by Application (2017-2028)
Figure 27. Europe Personalized Medicines Market Size Share by Country (2017-2028)
Figure 28. Germany Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Personalized Medicines Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Personalized Medicines Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Personalized Medicines Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Personalized Medicines Market Size Share by Region (2017-2028)
Figure 38. China Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Personalized Medicines Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Personalized Medicines Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Personalized Medicines Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Personalized Medicines Market Size Share by Country (2017-2028)
Figure 48. Mexico Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Personalized Medicines Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Personalized Medicines Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Personalized Medicines Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Personalized Medicines Market Size Share by Country (2017-2028)
Figure 54. Turkey Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Personalized Medicines Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. 3G Biotech Revenue Growth Rate in Personalized Medicines Business (2017-2022)
Figure 58. Quest Diagnostics Revenue Growth Rate in Personalized Medicines Business (2017-2022)
Figure 59. Laboratory Corporation of America Revenue Growth Rate in Personalized Medicines Business (2017-2022)
Figure 60. Abbott Revenue Growth Rate in Personalized Medicines Business (2017-2022)
Figure 61. Agendia NV Revenue Growth Rate in Personalized Medicines Business (2017-2022)
Figure 62. Asuragen Inc Revenue Growth Rate in Personalized Medicines Business (2017-2022)
Figure 63. Becton Dickinson Revenue Growth Rate in Personalized Medicines Business (2017-2022)
Figure 64. CardioDx Inc. Revenue Growth Rate in Personalized Medicines Business (2017-2022)
Figure 65. Foundation Medicine Revenue Growth Rate in Personalized Medicines Business (2017-2022)
Figure 66. Qiagen Revenue Growth Rate in Personalized Medicines Business (2017-2022)
Figure 67. Siemens Healthcare Revenue Growth Rate in Personalized Medicines Business (2017-2022)
Figure 68. Amgen Revenue Growth Rate in Personalized Medicines Business (2017-2022)
Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Personalized Medicines Business (2017-2022)
Figure 70. GE Healthcare Revenue Growth Rate in Personalized Medicines Business (2017-2022)
Figure 71. Pfizer Revenue Growth Rate in Personalized Medicines Business (2017-2022)
Figure 72. Sanofi Revenue Growth Rate in Personalized Medicines Business (2017-2022)
Figure 73. 23andMe Revenue Growth Rate in Personalized Medicines Business (2017-2022)
Figure 74. Illumina Revenue Growth Rate in Personalized Medicines Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Personalized Medicines Market

Leave This Empty: